These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 29370229)
1. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation. Bassand JP; Accetta G; Al Mahmeed W; Corbalan R; Eikelboom J; Fitzmaurice DA; Fox KAA; Gao H; Goldhaber SZ; Goto S; Haas S; Kayani G; Pieper K; Turpie AGG; van Eickels M; Verheugt FWA; Kakkar AK; PLoS One; 2018; 13(1):e0191592. PubMed ID: 29370229 [TBL] [Abstract][Full Text] [Related]
2. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK; BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652 [TBL] [Abstract][Full Text] [Related]
3. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry. Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK; JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873 [TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry. Yamashita Y; Takagi D; Hamatani Y; Iguchi M; Masunaga N; Esato M; Chun YH; Itoh H; Nishimura M; Wada H; Hasegawa K; Ogawa H; Abe M; Akao M Heart Vessels; 2016 Dec; 31(12):2025-2034. PubMed ID: 26973346 [TBL] [Abstract][Full Text] [Related]
5. The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events. Atar D; Berge E; Le Heuzey JY; Virdone S; Camm AJ; Steffel J; Gibbs H; Goldhaber SZ; Goto S; Kayani G; Misselwitz F; Stepinska J; Turpie AGG; Bassand JP; Kakkar AK; Europace; 2020 Feb; 22(2):195-204. PubMed ID: 31747004 [TBL] [Abstract][Full Text] [Related]
6. Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry. Apenteng PN; Gao H; Hobbs FR; Fitzmaurice DA; BMJ Open; 2018 Jan; 8(1):e018905. PubMed ID: 29331969 [TBL] [Abstract][Full Text] [Related]
7. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study. Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375 [TBL] [Abstract][Full Text] [Related]
8. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406 [TBL] [Abstract][Full Text] [Related]
9. Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry. Pope MK; Atar D; Svilaas A; Hole T; Nielsen JD; Hintze U; Crisby M; Raatikainen P; Airaksinen KEJ; Virdone S; Pieper K; Kayani G; Le Heuzey JY; Steffel J; Stepinska J; Bassand JP; Camm AJ; Ann Med; 2021 Dec; 53(1):485-494. PubMed ID: 33818226 [TBL] [Abstract][Full Text] [Related]